Cafergot suppositories in migraine.
D002110:Caffeine / Q000627:therapeutic use*; D002317:Cardiovascular Agents; D004338:Drug Combinations; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D004878:Ergotamine; D008881:Migraine Disorders / Q000628:therapy*; D010120:Oxytocics; D010570:Pessaries; D013488:Suppositories
D002317:Cardiovascular Agents; D004338:Drug Combinations; D004876:Ergot Alkaloids; D010120:Oxytocics; D013488:Suppositories; C037330:caffeine, ergotamine drug combination; D002110:Caffeine; D004878:Ergotamine
CAFFEINE/therapeutic use; ERGOT ALKALOIDS/therapeutic use; MIGRAINE/therapy; SUPPOSITORIES